Skip to content

    Medi Assist Healthcare Services Limited

    MEDIASSISTGood
    Financial Services·5 Nov 2025
    Management Summary

    Medi Assist Healthcare Services reported strong top-line growth in Q2 and H1 FY26, driven by a 20.2% increase in premium under management to Rs. 12,719 crores. While total income grew significantly, profitability was impacted by the ongoing integration of Paramount TPA, which diluted Q2 EBITDA by 150 basis points, and strategic technology investments. Management outlined a clear path to normalize margins to 22-23% and achieve debt-free status by March-April 2026 as integration efforts mature and technology platforms scale.

    Highlights

    8
    • Total premium under management (PUM) administered grew 20.2% YoY to Rs. 12,719 crores as of September 30, 2025.

    • Q2 FY26 total income increased 25.5% YoY to Rs. 234.8 crores.

    • H1 FY26 total income grew 20.2% YoY to Rs. 432.8 crores.

    • Q2 FY26 EBITDA (excluding other income) was Rs. 39.7 Cr, a 3.3% YoY growth, with a margin of 17.1% on operating revenue.

    • Q2 FY26 Profit After Tax (PAT) declined 61.5% YoY to Rs. 8.1 Cr, impacted by Paramount acquisition costs and technology investments.

    • Paramount acquisition resulted in a 150 bps impact on Q2 EBITDA, with an additional 100 bps impact from technology investments.

    • The company expects to become debt-free by March-April 2026.

    • Management aims to restore core business EBITDA margins to 22-23% within 4-5 quarters as integration matures.

    What Changed2

    vs Q3 FY26

    Guidance items5 → 4 (-1)Q&A highlights6 → 3 (-3)
    Key financials

    Metrics

    13

    Periods

    3

    Headline

    7
    • Total PUM (Sep 30, 2025)
      ₹12,719 Cr
      YoY+20.2%
    • H1 FY26 Total Income
      ₹432.8 Cr
      YoY+20.2%
    • H1 FY26 Operating Revenue
      ₹423.1 Cr
      YoY+21.4%
    • H1 FY26 EBITDA
      ₹81.7 Cr
      YoY+10.9%
    • H1 FY26 EBITDA Margin
      19.3%

    Q2 FY26

    5
    • Total Income
      ₹234.8 Cr
      YoY+25.5%
    • Operating Revenue
      ₹232.5 Cr
      YoY+28.6%
    • EBITDA
      ₹39.7 Cr
      YoY+3.3%
    • EBITDA Margin
      17.1%
    • PAT
      ₹8.1 Cr
      YoY-61.5%

    H1 FY26

    1
    • Tech Delivered Savings
      ₹230 Cr
      YoY+50%

    Segment breakdown

    Government BusinessInternational Business Administration
    Operating Revenue Contribution (Q2 FY26)12.6%4.3%
    Operating Revenue Contribution (H1 FY26)11.9%4.9%
    Heatmap· 2 shared metrics

    Guidance & targets

    4
    CategoryTargetPriority
    Debt
    Debt-free status
    Debt-free
    High
    Margin
    Core Business EBITDA Margin
    22-23%
    High
    Integration
    Paramount Integration Completion
    4 to 5 quarters
    Medium
    SaaS Business
    SaaS Business Profitability
    Accretive to overall margin profile
    Medium

    Risks & concerns

    4
    RiskSeverity

    Initial low profitability and integration costs of Paramount acquisition

    Paramount's low profitability and integration efforts are currently impacting consolidated EBITDA and PAT, leading to a 150 bps dilution in Q2 EBITDA, but expected to normalize within 4-5 quarters.Management acknowledged

    medium

    Increased depreciation and amortization due to Paramount acquisition

    The PPA exercise for Paramount created intangible assets, leading to a spike in D&A, which will keep reported PAT lower for a few years until customer retention relationship amount normalizes.Management acknowledged

    medium

    Upfront technology investment costs impacting current profitability

    Current technology investments are impacting EBITDA by 100 bps, but are crucial for future growth and are expected to yield higher gross margins in the long run as volumes ramp up.Management acknowledged

    medium

    Timing issues with large project collections impacting trade receivables

    Trade receivables temporarily increased due to timing issues with one or two large project collections between September and October, but management stated these have since been collected and are back to normal.Management acknowledged

    low

    Q&A highlights

    3

    “in general, in 4 to 5 quarters, you should see the combined business getting back closer to the original margin profile that is prior to the acquisition.”

    This question addresses the primary reason for current PAT decline and provides a clear timeframe for recovery, crucial for investor valuation.

    asked by Jayesh Gandhi

    3 min read6 chapters

    Detailed Narrative

    01

    Strong Top-line Growth Amidst Strategic Shifts

    Medi Assist reported a robust 20.2% year-on-year growth in total premium under management (PUM), reaching Rs. 12,719 crores as of September 30, 2025. This was driven by a 22.5% YoY increase in group premiums to Rs. 11,447 crores. Total income for Q2 FY26 grew 25.5% YoY to Rs. 234.8 crores, and for H1 FY26, it increased 20.2% YoY to Rs. 432.8 crores, reflecting strong operational performance. The company's market share in total health premiums in India expanded to 21.3% from 19.2% a year ago, with group segment market share rising to 32.2% from 28.4%.

    02

    Paramount Acquisition and Integration Impact

    The ongoing integration of Paramount TPA significantly impacted Q2 FY26 profitability, leading to a 150 basis points dilution in EBITDA. Paramount contributed Rs. 488 crores to group premiums and Rs. 104 crores to retail premiums. Management indicated that the full integration process, including the normalization of Paramount's profitability to Medi Assist's original margin profile, is expected to take 4 to 5 quarters. This acquisition also led to increased depreciation and amortization due to intangible asset creation, which will likely remain at the current run rate for a few years.

    03

    Strategic Technology Investments and SaaS Growth

    Medi Assist continues to invest heavily in technology, with an estimated 100 basis points impact on Q2 EBITDA from these investments. The company successfully deployed its MAtrix claims platform with Star Health and Allied Insurance, with 40% of claims volume already migrated. Technology-driven fraud, waste, and abuse prevention activities delivered savings of Rs. 230 crores in H1 FY26, a 50% increase YoY. The Raksha Prime AI/ML-based instant checkout offering enabled over 156,000 discharges in H1 FY26. SaaS revenues currently constitute 2% of total revenues, with expectations for higher gross margins at steady state as the platform scales.

    04

    Profitability and Margin Outlook

    Q2 FY26 EBITDA (excluding other income) grew 3.3% YoY to Rs. 39.7 crores, with a margin of 17.1% on operating revenue. However, Q2 PAT declined 61.5% YoY to Rs. 8.1 crores, and H1 PAT declined 23.3% YoY to Rs. 30.7 crores, primarily due to Paramount's lower profitability, integration costs, and higher depreciation/amortization. Management expressed confidence in restoring core business EBITDA margins to 22-23% within the next 4 to 5 quarters as integration benefits materialize and technology investments yield returns, though reported PAT may remain subdued due to accounting impacts.

    05

    Debt Reduction and Balance Sheet Health

    As of September 30, 2025, the company reported a net cash balance of minus Rs. 20.9 crores and a net worth of Rs. 591.2 crores. Current debt stands at approximately Rs. 245 crores, with Rs. 150 crores expected to be paid off in the next 1-2 months. Management provided a clear target to achieve debt-free status by March-April 2026, driven by strong cash generation from the business. This commitment aims to strengthen the balance sheet and reduce financing costs, improving overall financial health.

    06

    Retail Segment Focus and Market Share Dynamics

    While the group segment saw robust growth, retail premium growth was modest at 2.6% YoY, reaching Rs. 1,272 crores, and retail market share slightly declined to 5.3% from 5.6%. However, premiums administered for private and SAHI insurers in the retail segment grew significantly by 47.7% YoY. Management is bullish on the retail opportunity, leveraging its MAtrix platform and AI engine for fraud prevention to make a significant dent in market share. The recent GST exemption for retail health policies is expected to be beneficial and accretive to the whole industry in the long run.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.